VAVŘINA, Martin, Jiří ŽUREK, Michal FEDORA, Petr DOMINIK, Marie FORBELSKÁ and Julie BIENERTOVÁ VAŠKŮ. Reduction of paediatric emergence agitation after adenotonsillectomy with nalbuphine. Current Pediatric Research. Aligarh: Scientific Publishers of India, 2017, vol. 21, No 3, p. 490-496. ISSN 0971-9032.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Reduction of paediatric emergence agitation after adenotonsillectomy with nalbuphine
Authors VAVŘINA, Martin (203 Czech Republic, guarantor, belonging to the institution), Jiří ŽUREK (203 Czech Republic, belonging to the institution), Michal FEDORA (203 Czech Republic, belonging to the institution), Petr DOMINIK (203 Czech Republic, belonging to the institution), Marie FORBELSKÁ (203 Czech Republic, belonging to the institution) and Julie BIENERTOVÁ VAŠKŮ (203 Czech Republic, belonging to the institution).
Edition Current Pediatric Research, Aligarh, Scientific Publishers of India, 2017, 0971-9032.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30209 Paediatrics
Country of publisher India
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/17:00098198
Organization unit Faculty of Medicine
Keywords in English Anaesthesia; Opioid analgesics; Volatile anaesthetics; Sevoflurane; Child; Emergence delirium
Tags alphentanil, anesthesia, EL OK, nalbuphine, pediatrics, podil
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 22/3/2018 15:43.
Abstract
Abstract Background and aim: The aim of this prospective, observational study was to evaluate the potential benefit of nalbuphine in paediatric adenotonsillectomy in comparison to alfentanil in the terms of the emergence delirium and other procedural adverse events. Methods: Monitored adverse events were tachycardia, dyspnoea, hypotension, hypertension and emergence agitation according to the adapted Watcha scale. All eligible patients were given oral premedication and general anaesthesia was induced using inhalational or intravenous route. Patients were given nalbuphine (0.1-0.2 mg.kg-1) or alfentanil (10-15 ug.kg-1) and had all requested data recorded in the study form (age, study group, metamizole usage, body weight, total dose of nalbuphine or alfentanil, ASA, studied parameters). Results: Total of 122 patients were enrolled for this study, 8 patients were excluded because of incomplete study form. This resulted in study population of 114 patients. All patients were ASA I–II. No differences in age or body weight were observed. Emergence agitation was significantly (p=0.024) more frequent in the Alfentanil group (39.66%) than in Nalbuphine group (19.64%). Tachycardia was significantly more frequent in younger patients. Dyspnoea was significantly dose-dependent and more frequent in lower dosages (p=0.045). Hypertension was more frequent in patients with higher grade of agitation, but statistically significant only in the Alfentanil group (p=0.044). Conclusion: Nalbuphine in the setting of paediatric adenotonsillectomy makes a good alternative to short acting opioid and postoperative analgesia using NSAID or other nonopioid analgesics. Our results show that nalbuphine provides less emergence agitation and therefore provides a patient better early postoperative outcome.
PrintDisplayed: 19/7/2024 11:24